Tower Research Capital LLC (Trc) Coherus Bio Sciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,502 shares of CHRS stock, worth $12,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,502

Previous 15,773 33.42%

Holding current value

$12,392

Previous $27,000 62.96%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.99 - $1.8 $5,218 - $9,487	-5,271 Reduced 33.42%	10,502 $10,000
Q2 2024 Aug 13, 2024	BUY	$1.58 - $2.51 $24,921 - $39,590	15,773 New	15,773 $27,000
Q4 2023 Feb 13, 2024	SELL	$1.59 - $3.85 $655 - $1,586	-412 Reduced 3.07%	13,003 $43,000
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $39,756 - $57,933	10,630 Added 381.69%	13,415 $50,000
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $41,765 - $91,466	-11,020 Reduced 79.83%	2,785 $11,000
Q1 2023 May 09, 2023	BUY	$5.89 - $10.52 $54,900 - $98,056	9,321 Added 207.87%	13,805 $95,000
Q4 2022 Feb 10, 2023	SELL	$5.69 - $10.07 $253,096 - $447,923	-44,481 Reduced 90.84%	4,484 $36,000
Q3 2022 Nov 10, 2022	BUY	$7.17 - $13.87 $84,326 - $163,125	11,761 Added 31.61%	48,965 $470,000
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $143,464 - $323,896	24,482 Added 192.44%	37,204 $269,000
Q1 2022 May 12, 2022	BUY	$10.92 - $16.41 $6,693 - $10,059	613 Added 5.06%	12,722 $164,000
Q4 2021 Feb 14, 2022	BUY	$15.81 - $18.99 $63,445 - $76,206	4,013 Added 49.57%	12,109 $193,000
Q3 2021 Nov 15, 2021	BUY	$12.68 - $17.79 $5,769 - $8,094	455 Added 5.95%	8,096 $130,000
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $136,505 - $162,436	-10,541 Reduced 57.97%	7,641 $106,000
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $237,151 - $351,779	16,446 Added 947.35%	18,182 $266,000
Q4 2020 Feb 16, 2021	SELL	$16.56 - $18.94 $44,397 - $50,778	-2,681 Reduced 60.7%	1,736 $30,000
Q3 2020 Nov 16, 2020	SELL	$17.41 - $19.89 $161,007 - $183,942	-9,248 Reduced 67.68%	4,417 $81,000
Q2 2020 Aug 13, 2020	BUY	$14.43 - $19.16 $197,185 - $261,821	13,665 New	13,665 $244,000
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $86,743 - $167,465	-7,433 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$16.33 - $21.37 $79,821 - $104,456	4,888 Added 192.06%	7,433 $134,000
Q3 2019 Nov 05, 2019	BUY	$16.3 - $23.37 $41,483 - $59,476	2,545 New	2,545 $52,000
Q3 2018 Nov 13, 2018	SELL	$14.45 - $20.25 $121,697 - $170,545	-8,422 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$10.25 - $17.45 $86,325 - $146,963	8,422 New	8,422 $118,000
Q1 2018 May 15, 2018	SELL	$9.1 - $13.7 $25,652 - $38,620	-2,819 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$8.35 - $14.4 $609 - $1,051	-73 Reduced 2.52%	2,819 $25,000
Q3 2017 Nov 14, 2017	BUY	$11.1 - $14.5 $32,101 - $41,934	2,892	2,892 $39,000

Others Institutions Holding CHRS

# of Institutions

132

Shares Held

76.9M

Call Options Held

40.7K

Put Options Held

50.1K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Coherus Bio Sciences, Inc. Transaction History